Search details
1.
Immunogenicity and efficacy of âââââââââheterologous ChAdOx1-BNT162b2 vaccination.
Nature
; 600(7890): 701-706, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34673755
2.
Metabolites and secretory immunoglobulins: messengers and effectors of the host-microbiota intestinal equilibrium.
Trends Immunol
; 43(1): 63-77, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34848167
3.
Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.
Clin Microbiol Rev
; 36(3): e0016422, 2023 09 21.
Article
in English
| MEDLINE | ID: mdl-37306571
4.
Reduction of product composition variability using pooled microbiome ecosystem therapy and consequence in two infectious murine models.
Appl Environ Microbiol
; : e0001624, 2024 Apr 23.
Article
in English
| MEDLINE | ID: mdl-38651930
5.
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination.
Immunol Rev
; 296(1): 169-190, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32594569
6.
Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants.
J Clin Immunol
; 43(1): 31-45, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36006568
7.
Human Secretory IgM: An Elusive Player in Mucosal Immunity.
Trends Immunol
; 41(2): 141-156, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31928913
8.
Proof-of-Concept Human Organ-on-Chip Study: First Step of Platform to Assess Neuro-Immunological Communication Involved in Inflammatory Bowel Diseases.
Int J Mol Sci
; 24(13)2023 Jun 24.
Article
in English
| MEDLINE | ID: mdl-37445748
9.
Association of gut-specific non-inflammatory T lymphocytes with chronic anorexia nervosa and constitutional thinness.
Eur Eat Disord Rev
; 31(1): 76-86, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35751889
10.
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID.
Am J Gastroenterol
; 117(9): 1482-1490, 2022 09 01.
Article
in English
| MEDLINE | ID: mdl-35973142
11.
Evaluation of Commercial Anti-SARS-CoV-2 Antibody Assays and Comparison of Standardized Titers in Vaccinated Health Care Workers.
J Clin Microbiol
; 60(1): e0174621, 2022 01 19.
Article
in English
| MEDLINE | ID: mdl-34705539
12.
Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10® to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies.
Int J Mol Sci
; 23(17)2022 Aug 24.
Article
in English
| MEDLINE | ID: mdl-36076966
13.
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501).
BMC Immunol
; 22(1): 81, 2021 12 25.
Article
in English
| MEDLINE | ID: mdl-34953484
14.
Impact of IgA isoforms on their ability to activate dendritic cells and to prime T cells.
Eur J Immunol
; 50(9): 1295-1306, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32277709
15.
No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification.
Dig Dis Sci
; 66(8): 2744-2749, 2021 08.
Article
in English
| MEDLINE | ID: mdl-32936345
16.
Impact of Host Immune Status on Discordant Anti-SARS-CoV-2 Circulating B Cell Frequencies and Antibody Levels.
Int J Mol Sci
; 22(20)2021 Oct 14.
Article
in English
| MEDLINE | ID: mdl-34681752
17.
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial.
Gut
; 69(7): 1206-1212, 2020 07.
Article
in English
| MEDLINE | ID: mdl-31980448
18.
Infliximab levels and antibodies in IBD-related peripheral arthralgia.
Int J Colorectal Dis
; 35(6): 1141-1148, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32296932
19.
Risankizumab concentration but not IL-22 levels are associated with clinical and biochemical remission in patients with Crohn's disease.
Clin Gastroenterol Hepatol
; 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38705437
20.
Concentrations of Ustekinumab During Induction Therapy Associate With Remission in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol
; 17(12): 2610-2612, 2019 11.
Article
in English
| MEDLINE | ID: mdl-30851477